Nebula Research & Development LLC Sells 32,959 Shares of National Vision Holdings, Inc. (NASDAQ:EYE)

Nebula Research & Development LLC lessened its holdings in shares of National Vision Holdings, Inc. (NASDAQ:EYE - Free Report) by 44.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,789 shares of the company's stock after selling 32,959 shares during the quarter. Nebula Research & Development LLC owned about 0.05% of National Vision worth $435,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Boston Partners purchased a new stake in National Vision during the fourth quarter valued at about $12,594,000. Arrowstreet Capital Limited Partnership increased its position in shares of National Vision by 81.5% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,308,375 shares of the company's stock valued at $24,053,000 after purchasing an additional 1,036,459 shares during the last quarter. FIL Ltd purchased a new position in shares of National Vision during the 4th quarter valued at about $2,605,000. Emerald Advisers LLC lifted its position in National Vision by 23.1% in the 4th quarter. Emerald Advisers LLC now owns 991,100 shares of the company's stock worth $10,327,000 after buying an additional 186,014 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in National Vision by 38.6% in the fourth quarter. Renaissance Technologies LLC now owns 664,900 shares of the company's stock worth $6,928,000 after buying an additional 185,300 shares in the last quarter.

Analyst Ratings Changes

EYE has been the topic of several research reports. Wells Fargo & Company lifted their price target on shares of National Vision from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 27th. Citigroup lifted their target price on shares of National Vision from $12.00 to $13.00 and gave the stock a "neutral" rating in a research report on Friday, March 7th. Morgan Stanley cut their price target on shares of National Vision from $14.00 to $13.00 and set an "equal weight" rating for the company in a research report on Tuesday, January 21st. Finally, Barclays boosted their target price on National Vision from $12.00 to $14.00 and gave the company an "equal weight" rating in a research note on Monday, March 3rd. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $14.00.

National Vision Trading Up 1.8 %

NASDAQ:EYE traded up $0.23 during mid-day trading on Monday, reaching $13.37. 562,715 shares of the company's stock traded hands, compared to its average volume of 1,670,473. The company has a 50 day moving average price of $12.16 and a 200-day moving average price of $11.55. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of -66.85, a PEG ratio of 3.27 and a beta of 1.02. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.57 and a quick ratio of 0.37. National Vision Holdings, Inc. has a 12-month low of $9.56 and a 12-month high of $18.68.

National Vision Profile

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.